KS

Kajal Sameer Medda

Director Director DIN 08046687
DIN 08046687 First appointment Jan 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2018
Shareholding value Locked Premium profile

About Kajal Sameer Medda

Data last updated:

Kajal Sameer Medda has 8 years in corporate governance. Formerly with 1 company, such as Unibron Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08046687
Primary Designation Director
First Appointment 08 Jan 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director08 Jan 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Unibron Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Kajal Sameer Medda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kajal Sameer Medda

Kajal Sameer Medda has 8 years in corporate governance. Formerly with 1 company, such as Unibron Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Kajal Sameer Medda is associated with 0 companies as a director.

Kajal Sameer Medda has expertise in General Business.

Kajal Sameer Medda has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available